All Webcasts > When Should I Perform Point-of-Care Fluorescence Imaging of Wound Bioburden?
When Should I Perform Point-of-Care Fluorescence Imaging of Wound Bioburden? Guidelines based on Delphi Consensus
A Delphi Consensus was created to establish guidelines on fluorescence imaging of bacterial burden (MolecuLight i:X), the only point-of-care solution to visualize the presence of significant bacterial burden (>104 CFU/g) in wounds.
Join 5 of the authors of the Delphi Consensus as they discuss:
- Clinical indications for fluorescence imaging (e.g., delayed wound healing, before and after debridement, before placement of cellular and tissue-based products)
- Recommended frequency of fluorescence imaging
- Real-world impact of fluorescence imaging on clinical decision making and associated wound outcomes
Fluorescence Imaging Guidelines
Videos Recommended for You
Learn more about our new Reimbursement Pathway
If you’d like to learn how the MolecuLight i:X can help your practice, you can book a demonstration here.